Caveolin-1 opens endothelial cell junctions by targeting catenins. by Kronstein, R. et al.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Caveolin-1 opens endothelial cell junctions
by targeting catenins
Romy Kronstein1, Jochen Seebach2, Sylvia Großklaus1, Carsten Minten3,
Britta Engelhardt 3, Marek Drab4, Stefan Liebner5, Yvan Arsenijevic6,
Abdallah Abu Taha2, Tatiana Afanasieva1, and Hans-Joachim Schnittler 2*
1Institute of Physiology, Medical Faculty of the TU-Dresden, Dresden, Germany; 2Institute of Anatomy and Vascular Biology, Vesaliusweg 2-4, Westfa¨lische Wilhelms-University of Mu¨nster,
Mu¨nster, Germany; 3Theodor Kocher Institute, University of Bern, Bern, Switzerland; 4Institute of Immunology and Experimental Therapy, Wroclaw, Poland; 5Institute of Neurology, Johann
Wolfgang Goethe-University Frankfurt, Frankfurt, Germany; and 6Jules Gonin Eye Hospital, University of Lausanne, Lausanne, Switzerland
Received 8 March 2011; revised 21 September 2011; accepted 26 September 2011; online publish-ahead-of-print 29 September 2011
Time for primary review: 30 days
Aims A fundamental phenomenon in inflammation is the loss of endothelial barrier function, in which the opening of endo-
thelial cell junctions plays a central role. However, the molecular mechanisms that ultimately open the cell junctions
are largely unknown.
Methods
and results
Impedance spectroscopy, biochemistry, and morphology were used to investigate the role of caveolin-1 in the regu-
lation of thrombin-induced opening of cell junctions in cultured human and mouse endothelial cells. Here, we demon-
strate that the vascular endothelial (VE) cadherin/catenin complex targets caveolin-1 to endothelial cell junctions.
Association of caveolin-1 with VE-cadherin/catenin complexes is essential for the barrier function decrease in
response to the pro-inflammatory mediator thrombin, which causes a reorganization of the complex in a rope
ladder-like pattern accompanied by a loss of junction-associated actin filaments. Mechanistically, we show that in
response to thrombin stimulation the protease-activated receptor 1 (PAR-1) causes phosphorylation of caveolin-
1, which increasingly associates with b- and g-catenin. Consequently, the association of b- and g-catenin with VE-
cadherin is weakened, thus allowing junction reorganization and a decrease in barrier function. Thrombin-induced
opening of cell junctions is lost in caveolin-1-knockout endothelial cells and after expression of a Y/F-caveolin-1
mutant but is completely reconstituted after expression of wild-type caveolin-1.
Conclusion Our results highlight the pivotal role of caveolin-1 in VE-cadherin-mediated cell adhesion via catenins and, in turn, in
barrier function regulation.
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1. Introduction
Vascular endothelial (VE) cells form a barrier that controls the
exchange of fluid and solutes between the vasculature and the inter-
stitial tissue. The calcium-dependent VE-cadherin, and its associated
catenins, control cell–cell adhesion, and paracellular barrier function
and are important for the formation of tight junction complexes.1,2
The VE-cadherin/catenin complex can be found in all endothelial
cells and represents the predominant structure in endothelial junc-
tions of postcapillary venules, a location where cell junctions prefer-
entially open during inflammation and leucocyte diapedesis.1,2
VE-cadherin has a carboxy-terminal domain that binds b-catenin,
g-catenin and p120ctn.1,2 Both b- and g-catenins bind a-catenin,
which was previously suggested to connect the complex directly
to actin filaments.1,2 However, this concept was challenged by data
showing that a-catenin is an allosteric molecule incapable of
binding to both b-catenin and actin filaments at the same time.3
Recently, the epithelial protein lost in neoplasms (EPLIN) was
shown to bind both actin filaments and a-catenin in epithelial
cells,4 indicating that the a-catenin/EPLIN protein-chain might
bridge the gap between cadherins and actin filaments. We were
able to confirm that endothelial cells of human and mouse origin
also express ELPIN (Taha and Schnittler, unpublished data).
However, it is generally accepted that the VE-cadherin/catenin
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complex is functionally linked to actin filaments1,2 and that this inter-
action is critical in junction regulation.
Transient increases in paracellular permeability in response to acti-
vation of PAR-1 (proteinase-activated receptor-1) by thrombin cause
redistribution of VE-cadherin and catenins from a continuous band
into a discontinous streak-like pattern with loss of junction-associated
actin filaments and stress fibre formation. This process involves the
activation of Rho-GTPases, the kinases PI3K, src, and PKC, actin/
myosin contractility, myosin light chain kinases and phosphatases,
and the tyrosine phosphatase VEPTP (for review see).1,2 In contrast,
tightening of cell junctions depends on VE-cadherin clustering
accompanied by recruitment of junction-associated actin filaments
via rac-1.5 Although a number of relevant mechanisms have been
identified, the causal mechanism that ultimately induces opening of
endothelial cell junctions in inflammation (e.g. after thrombin admin-
istration) is still unknown.
Many studies have provided compelling evidence that caveolin-1,
the main scaffolding protein of caveolae,6 binds to signalling mol-
ecules7 and is involved in regulating endothelial permeability, angio-
genesis,8 – 10 and leucocyte diapedesis.11 Caveolin-1 is composed of
a lipophilic, hairpin-shaped, helical sequence embedded in the inner
leaflet of the plasma membrane with both N- and C-terminal cyto-
plasmic domains. The N-terminus binds to many signalling molecules,
including endothelial nitric oxide synthase (eNOS), src kinase, PKCa,
and G-proteins and is required for caveolin multimerization.7 Previous
studies on the role of caveolin-1 in endothelial permeability have
reported both positive10,12,13 and negative8,14 effects. Caveolin-1 can
be precipitated with VE-cadherin and E-cadherin13,15 and interacts
with b-catenin in zebrafish.16 Thus, caveolin-1 might have a more
general role in regulating cell junctions, but its molecular regulation
of endothelial cell adhesion and barrier function needs to be
defined. Here, we show that localization of caveolin-1 to endothelial
cell junctions depends on the VE-cadherin/catenin complexes and
that thrombin-induced increase in paracellular permeability is
phosphocaveolin-1 dependent.
2. Methods
2.1 Antibodies and reagents
The antibodies and reagents used and their sources are listed in
Supplementary material online, (SI-6).
2.2 Primary endothelial cell cultures, Chinese
hamster ovary cells, endothelioma cell lines,
immunofluorescence microscopy, and
transendothelial electrical resistance
Human umbilical cord vein endothelial cells (HUVEC) were isolated from
anonymized donors as described17 according to the principles outlined in
the Declaration of Helsinki; this was approved by the ethics boards of
TU-Dresen and the WW-University of Mu¨nster (EK 203112005 and
2009–537-f-S, respectively). Cells of passage 1 were used for exper-
iments. Wild-type CHO (Chinese hamster ovary) cells and
VE-cadherin-expressing CHO cells were cultured as described else-
where.18 Caveolin-1-deficient and wild-type endothelioma cell lines
were established from hearts of caveolin-1-deficient newborn mice19
and wild-type mice, respectively, as previously described.20 Animals
were sacrificed by cervical dislocation in accordance to the German
animal protection law and to the Guide for the Care and Use of Laboratory
Animals published by the US National Institutes of Health (NIH Publication
No.85–23, revised 1996). A b-catenin-deficient cell line was a kind gift
from Elisabetta Dejana, Milano, and cultured as described.21 Immunolabel-
ling was carried out as previously described17 and detected using a
laser-scanning microscope (LSM 510 Zeiss, Jena, Germany). Transen-
dothelial electrical resistance (TER) of endothelial cell cultures was deter-
mined from impedance spectroscopy data.5 Endothelioma cell cultures
having a TER .3 Vcm2, a value sufficient to evaluate endothelial
barrier function by impedance spectroscopy, were used for experiments.
2.3 Generation of recombinant
glutathione-S-transferase-tagged b-catenin
and VE-cadherin cytoplasmic domain
Recombinant murine glutathione-S-transferase (GST)2b-catenin was
expressed in E. coli BL21 using the pGEX 2T-1 expression vector
(kindly provided by William Weis and S. Pokutta, Stanford, USA) and pur-
ified as previously described.22 The recombinant cytoplasmic domain of
GST-VE-cadherin (GST-VE-cadcyto) was expressed in E. coli strain BL21
using the pGEX 4T-1 expression vector (kindly provided by
D. Vestweber, Mu¨nster, Germany). GST-VE-cadcyto was purified using a
GSTrapTM FF glutathione-sepharose column (GE-Healthcare, Uppsala,
Sweden) according to the manufacturers’ instruction manual.
2.4 GST pull-down assays
Either GST-tagged b-catenin or VE-cadcyto (65 nM) was bound for 1 h at
48C to glutathione sepharose in binding buffer (20 mM Tris/HCl, pH 7.4,
150 mM NaCl, 1% Triton-X-100) and washed three times in 1 mL of
phosphate-buffered saline containing 0.5% Triton X-100, 1 mM dithio-
threitol (DTT) and 1 mM PMSF (washing buffer). HUVEC cell cultures
(7 × 106 cells) were lysed for 15 min at 48C in lysis buffer (50 mM Tris/
HCl, pH 7.6, 150 mM NaCl, 1% Triton X-100, 1 mM PMSF, 5 mM DTT,
and proteinase inhibitors), and pelleted at 10 000 g for 5 min. Precleared
supernatants were subsequently adjusted to 650 mg total protein/mL and
a total volume of 800 mL. GST-b-catenin- or GST-VE-cadcyto-loaded glu-
tathione beads were applied to HUVEC cell lysates (7 × 106 cells) for 2 h
at 48C. After three washes using washing buffer, the samples were lysed in
SDS-sample buffer and analysed by SDS–PAGE and western blotting.
2.5 DNA plasmids, constructs, and production
of lentiviral vectors
Mouse caveolin-123 was cloned into the lentiviral vector pFUWG via the
BamHI and EcoRI cloning sites following PCR amplification with forward
primer 1 (5′-GATGGATCCATGTCTGGGGGCAAATACGTG-3′ , BamHI)
and reverse primer 2 (5′-GCCGAATTCTCATATCTCTTTCTGCGTGC-3′,
EcoRI). Cav-1-Y14F was generated by PCR amplification of fragment 1
using forward primer 3 (5′-GGACATCTCTTCACTGTTCCC-3′; base
exchange A/T is shown in bold) and reverse primer 2, and fragment 2
using forward primer 1 and reverse primer 4 (5′-GGGAA
CAGTGAAGAGATGTCC-3′). The two fragments were gel-purified and
annealed, and PCR was performed using primers 1 and 2. Purified PCR pro-
ducts were digested using BamHI and EcoRI and then cloned into the lenti-
viral vector pFUGW using the same cloning sites. Full-length mouse
b-catenin24 was amplified by PCR from the pCS2 + vector using the
forward primer (5′-CGGCTAGCCACCATGGCTACTCAAGCTGA
CCTG-3′) and the reverse primer (5′-CTCTAGAGTTACAGGTC
AGTATCAAACCA-3′). The purified PCR product was digested by NheI
and XbaI and cloned into the lentiviral vector pFUGW. All constructs
were verified by sequencing. Lentiviruses were produced by triple transfec-
tion of 293 T cells with pFUGW carrying the gene of interest, packaging
vectors, and pMD2G carrying the VSV glycoprotein as described else-
where.25 Viral stocks were titrated by HIV-1 ELISA according to the manu-
facturers’ directions (Zeptometrix Coorperation, Buffalo, USA). Gene
transduction into endothelioma cells was performed using 10 TU/cell.
Gene transduction efficiency was .90%, as scored by the number of
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caveolin-1-positive cells. Lentivirus-mediated gene transfer was non-toxic
as tested by determination of endothelial barrier function, growth, and mor-
phology. Protein expression was verified by quantitative western blot analy-
sis and immunofluorescence microscopy, as indicated.
2.6 Analysis of tyrosine phosphorylation,
immunoprecipitation, and western blotting
Tyrosine phosphorylation assay and quantitation was performed as
described elsewhere5 and outlined in the Supplementary material
online, (SI-7).
2.7 Quantification of western blots, cell
junction proteins, and statistical analyses
Quantitative western blots using total cell extracts (Figure 1) were per-
formed under standard conditions; prior to gel loading, total protein
was determined in SDS-dissolved samples,26 and defined amounts of
protein were loaded on each lane. Confluent cultures of HUVEC were
pooled (125 cm2 total) and subsequently divided in five different
samples, each used for quantitative immunoprecipitation (IP) of
VE-cadherin, a-catenin, b-catenin, ZO-1, and PECAM-1 followed by
western blotting. The optical density of the antibody band for each IP
was set to 1 and co-precipitated protein bands were related to this
amount. The same procedure was performed for g-catenin and caveolin-1
(not shown). Relative amounts of co-precipitated proteins shown in
Figures 4 and 6 were determined by relating the respective protein of stan-
dardized IP (compare IP) to the total amount of tubulin obtained from
each sample. The relative amounts of co-precipitated proteins were
obtained by ratio determination as indicated in each figure. Image
J-Software (NIH) was used to determine optical density of the specific
bands according to instructions.
Cell staining and image acquisitions were performed under standardized
conditions. Cell borders were manually selected as described elsewhere5
and fluorescence intensity was determined for each channel separately.
All data were tested for significance and standard deviation using GraphPad
Software Inc. (San Diego, USA; http://www.graphpad.com).
3. Results
3.1 Caveolin-1 associates with the
VE-cadherin/catenin complex
We first determined that caveolin-1 is an integral component
of the VE-cadherin/catenin complex in HUVECs, as indicated by
IP of VE-cadherin, a-, b-, or g-catenin, which yielded varying
amounts of caveolin-1 and associated junction proteins (Figure 1A
and B). IP of b-catenin and its homologue g-catenin yielded the
highest amount of caveolin-1 (10% of the total), whereas IP of
VE-cadherin yielded much less (Figure 1A and B). These interactions
were specific as IP of neither zonula occludens protein-1 nor
mouse IgG2a co-precipitated caveolin-1, VE-cadherin, or catenins
(Figure 1A and B). These results prompted us to test the ability
Figure 1 Caveolin-1 is found in a complex with junction molecules in endothelial cells. (A and B) Densitometry-based quantitative western blot
analyses of IP of VE-cadherin, a-catenin, b-catenin, ZO-1, g-catenin, PECAM-1, or unspecific mouse IgG2a from same amounts and volume of
Triton X-100 soluble cell extracts. (C) GST-b-catenin, or the GST-coupled cytoplasmic domain of VE-cadherin (GST-VE-cadcyto) was immobilized
to glutathione-S-sepharose beads and incubated with Triton X-100-soluble HUVEC cell lysates and probed by western blotting as indicated. Total
cell lysates served as a positive control. *P, 0.05; **P, 0.005; ***P, 0.0005.
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of GST-b-catenin and the GST-coupled cytoplasmic domain of
VE-cadherin (GST-VE-cadcyto) to precipitate caveolin-1 from endo-
thelial cell extracts. Indeed, GST-b-catenin, but not GST-VE-cadcyto
or GST-glutathione-sepharose, pulled down caveolin-1 (Figure 1C).
These data indicate that caveolin-1 associates with the
VE-cadherin/catenin complex in endothelial cells and requires
b-catenin for interaction. Since PECAM-1 was shown to be associ-
ated with both av/b3 integrin
27 and b-catenin,28 we expected
caveolin-1 in PECAM-1 immunoprecipitates. Indeed, IP of
PECAM-1 yielded a fraction containing both b-catenin and
caveolin-1 (Figure 1A and B).
3.2 Recruitment of caveolin-1 to cell
junctions depends on the VE-cadherin/
catenin complex
Immunostaining of confluent cultures of HUVEC showed that a frac-
tion of caveolin-1 localized along the cell junctions and appeared
superimposed with VE-cadherin, catenins, and PECAM-1 (Supplemen-
tary material online, SI-1).
To determine whether VE-cadherin and/or the catenins, in particu-
lar b-catenin, are important for the junction localization of caveolin-1,
we analysed the distribution of caveolin-1 in two different cell
systems: CHO cells and b-catenin-knockout endothelioma cells.21
CHO cells endogenously express caveolin-1 and small amounts of
b-catenin, but not a-catenin, g-catenin, PECAM-1, VE-cadherin, or
other classical cadherins (Figure 2A and B; Supplementary material
online, SI-2). In wild-type CHO cells neither b-catenin nor caveolin-1
was localized to the cell junctions (Figure 2A, a–d), while expression of
VE-cadherin recruited both the bulk of the b-catenin and a fraction of
the caveolin-1 (Figure 2A,e–h). Since VE-cadherin expression also
induced up-regulation of both b-catenin and a-catenin,29 but not
caveolin-1 (Figure 2B), we further investigated whether caveolin-1
recruitment to cell junctions was simply related to the increased
amount of b-catenin in VE-cadherin-expressing CHO cells. When
overexpressed in CHO cells (Figure 2C), b-catenin was predominantly
localized in the cytosol and caveolin-1 was not seen at cell junctions
(Figure 2A; i– l). Consistently, we found by IP that association of
caveolin-1 with b-catenin was high in VE-cadherin-expressing CHO
cells, much lower in b-catenin-overexpressing CHO cells, and negli-
gible in wild-type CHO cells (Figure 2D). Since caveolin-1 is a com-
ponent of a number of subcellular domains its interaction with
b-catenin requires spatial proximity at junctions as seen in
VE-cadherin-expressing CHO (Figure 2A; e– l) and endothelial cells
(Figures 3; Supplementary material online, SI-1). In addition, we used
b-catenin-knockout endothelial cells21 that still expresses
VE-cadherin, a- and g-catenin, and caveolin-1 (Supplementary
material online, SI-3). Since immunoprecipiates of g-catenin also
yield caveolin-1 (Figure 1), we found a small fraction of caveolin-1 at
cell junctions in b-catenin-knockout endothelial cells, as expected
(Figure 3A). Re-expression of b-catenin in b-catenin-knockout endo-
thelial cells increased the junction localization of caveolin-1 by a
factor of 2.5 (Figure 3A and B). This amount of caveolin-1 is compar-
able with the amount of caveolin-1 found in wild-type endothelial cells
of both murine and human origin. Thus, the VE-cadherin/catenin
complex is able to recruit caveolin-1 to cell junctions and b-catenin
greatly facilitates this effect.
3.3 Thrombin stimulation increases
formation of caveolin-1 complexes
with b- and g-catenin and decreases
association with VE-cadherin
The functional relevance of caveolin-1 complex formation with
VE-cadherin and catenins was tested by stimulation with thrombin,
a serine protease that cleaves the PAR-1 receptor and consequently
increases paraendothelial permeability.30 Impedance spectroscopy
was used to determine TER.5 One unit of thrombin was found to
transiently down-regulate TER to 70% of baseline values; the most sig-
nificant effect in HUVEC was seen 10–25 min post-stimulation, with
full recovery after 1 to 2 h (Figure 4A). Furthermore, standardized IP
of junction components revealed that thrombin stimulation decreased
the association of caveolin-1 with VE-cadherin to about one-third
after 20 min; this returned to pre-stimulation levels within 120 min
(Figure 4B and C ). In contrast, thrombin stimulation increased
caveolin-1 association with both b-catenin- and g-catenin by
two-fold in Triton X-100-soluble cell extracts as shown by IP of the
respective catenins (Figure 4B, D, and E). We performed IPs of cate-
nins instead of caveolin-1 as catenins appear to be target proteins
of caveolin-1 at cell junctions. Consistently, a fraction of b-catenin dis-
sociated from VE-cadherin after thrombin stimulation, as assayed by
VE-cadherin IP followed by b-catenin detection in Triton X-100 cell
extracts. This effect became increasingly apparent when the
b-catenin/VE-cadherin ratio was calculated (Figure 4F and G). These
effects were highly specific, since the amount of caveolin-1 bound
to a-catenin and PECAM-1 remained unchanged in response to
thrombin stimulation (Figure 4B, H, and I).
3.4 Remodelling of the VE-cadherin/catenin
complex during thrombin-induced opening
and reconstitution of cell junctions
Consistent with the thrombin-induced TER-minimum VE-cadherin
(Figure 5A), b-catenin (Figure 5B and C ), and g-catenin (not shown)
underwent remodelling from a continuous to an interrupted and rope
ladder-like pattern (Figure 5). A fraction of caveolin-1 localized at the
cell junctions under control conditions (Figure 5A) and underwent
remodelling in accordance with the redistribution of the VE-cadherin/
catenin complex into a rope ladder-like pattern, as shown for
b-catenin and caveolin-1 (Figure 5C). This remodelling was accompanied
by the characteristic loss of junction-associated actin filaments and the
development of stress fibres (Supplementary material online, SI-4).
During TER-recovery both caveolin-1 and the VE-cadherin/catenin
complex reappeared at the junctions after 120 min, as shown for
VE-cadherin and b-catenin (Figure 5A and D). The thrombin-induced
junction reorganization was also seen after stimulation of endothelial
cells with the PAR-1-specific PAR-1-activated peptide (PAR-1AP; not
shown). These data further support the concept that the impact of
caveolin-1 on junction regulation occurs via interaction with the
VE-cadherin/catenin complex.
3.5 Caveolin-1 is critical for the
transient breakdown of paracellular barrier
function
Since caveolin-1 can be activated by phosphorylation at tyrosine 14,31
we found a transient increase in phosphocaveolin-1 in b-catenin IP
after thrombin stimulation (Figure 6A), whereas the amount of
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Figure 2 VE-cadherin/catenin complexes target caveolin-1 to cell junctions in CHO cells. Wild-type CHO cells (CHO wt), CHO cells expressing
VE-cadherin (CHO-VE-cad), and CHO cells overexpressing b-catenin (CHO + b-cat) were immunolabelled for (A) VE-cadherin (panels a, e and i) or
triple-labelled for b-catenin, caveolin-1, and nuclear DNA (DAPI). Yellow colour indicates co-localization of b-catenin and caveolin-1 (arrows).
Expression of VE-cadherin but not b-catenin increased recruitment of both b-catenin and caveolin-1 to cell junctions. Inserts indicate confocal sec-
tions in the vertical plane of the z-stacks taken at the position shown by the white lines. Stars indicate same cell in the series. Bars ¼ 10 mm. (B) Total
cell lysates (20 mg/lane) were analysed by western blotting as indicated. HUVEC, positive control. Expression of VE-cadherin CHO wild-type (wt)
increased expression of b- and a-catenin. Alpha-tubulin, internal control. (C) Total cell lysates (10 mg/lane) as indicated were probed by western
blotting for b-catenin. Increased degradation of b-catenin is seen only in CHO wt + b-cat cells. (D) IP of b-catenin from cell lysates as indicated
was probed for either VE-cadherin or caveolin-1.
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phosphorylated caveolin-1 precipitated with the VE-cadherin antibody
remained unchanged (Figure 6A). To prove this concept, we generated
caveolin-1-knockout endothelioma cells and expressed the wild-type
caveolin-1 or caveolin-1 14Y/F (cav-1-Y/F), a mutant form of caveolin-1
that can no longer be phosphorylated at tyrosine 14 (Figure 6B). The
caveolin-1-knockout endothelioma cells are shown in the Supplemen-
tary material online, SI-5. Thrombin stimulation of caveolin-12/2
endothelial cells (cav2/2cells) did not decrease the TER, but rather
increased it slightly (Figure 6C). Expression of caveolin-1 in
caveolin-12/2 cells (cav2/2cells + cav-1) completely reconstituted
the thrombin response, while expression of the caveolin-1 Y/F mutant
(cav2/2cells + cav-1Y/F) did not. Thus, cav2/2cells + cav-1Y/F
behaved like cav2/2cells lacking caveolin-1 (Figure 6C). Under these
conditions, the association of caveolin-1 with b-catenin increased in
cav2/2cells + cav-1 but not in cav2/2cells + cav-1Y/F (Figure 6D
and E). Consistent with the hypothesis that phosphocaveolin-1 med-
iates dissociation of b-catenin from VE-cadherin, we found decreased
amounts of b-catenin in VE-cadherin IPs after thrombin application in
cav2/2cells + cav-1 but not in cav2/2cells or cav2/2cells +
cav-1Y/F. Rather, the addition of thrombin to cav2/2cells and cav2/2
cells + cav-1Y/F increased formation of b-catenin complexes with
VE-cadherin (Figure 6F). Together, these data provide direct evidence
that phosphocaveolin-1 is required to open intercellular junctions in
response to thrombin by increasing the formation of complexes with
catenins that dissociate from VE-cadherin.
4. Discussion
Regulation of paracellular endothelial barrier function requires a
concerted interplay between cell adhesion molecules and the
Figure 3 Caveolin-1 is increasingly recruited to endothelial cell junctions in the presence of b-catenin. (A) Immunolabelling of b-catenin, g-catenin,
caveolin-1, and nuclear DNA (DAPI) in b-catenin-deficient endothelial cells (b-cat 2/2) and b-cat 2/2 re-expressing b-catenin (b-cat
2/2 + b-cat) as indicated. Boxed areas within panels indicate those areas also shown at higher magnification. Z-stack: confocal sections in the vertical
plane of the z-stacks taken at the position of the white lines. Expression of b-catenin increased junction localization of caveolin-1, as seen by yellow
staining, indicating co-localization of caveolin-1 and g-catenin. Bars ¼ 10 mm. (B) Quantitative analysis of the co-localized caveolin-1 and g-catenin at
cell junctions. At least 200 cells of each type were analysed.
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Figure 4 Thrombin-induced barrier function decrease is associated with increased formation of catenin/caveolin-1 complexes that dissociate from
VE-cadherin. (A) Transendothelial electrical resistance (TER) was determined by impedance spectroscopy and plotted relative to baseline TER values
{TER/TER (0)} in HUVEC with and without 1 U/mL of thrombin. TER(0) values ranged between 8 and 15 Vcm2. n ¼ 3. ***P, 0.0005. (B–I) HUVEC
were treated with 1 U/mL of thrombin followed by IP of adherens junction proteins and subsequent quantitative western blotting, as indicated. Prior
to IP, nuclei-free Triton X-100 cell extracts from each experimental series were adjusted for equal protein content and equal volume. A sample of
20 mL was blotted and probed for a-tubulin content for internal control and quantification of relative protein amounts of co-precipitated proteins
(panels C1–E1, G1– I1). (B) Densitometry of western blots after IP with antibodies as indicated, n ¼ 3. (C2E, H– I ) One out of the three independent
western blots that were used for quantification as indicated is shown. (C) Caveolin-1 dissociated transiently from the VE-cadherin/catenin complex
after 20 min of thrombin stimulation, while caveolin-1 transiently increased its association with both (D and E) b-catenin and g-catenin. (F and G)
b-Catenin/VE-cadherin ratios were determined by densitometry of western blots (one out of three is seen in G) after thrombin stimulation.
(H and I ) Association of caveolin-1 with a-catenin and PECAM-1 remained unchanged. *P, 0.05; **P, 0.005; ***P, 0.0005.
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junction-associated actin cytoskeleton. The ability of caveolin-1 to
bind to and control certain regulatory molecules, such as src
kinases, G-proteins, and eNOS, as well as its ability to modulate
calcium signalling and permeability6,8,19,32,13 indicates a critical role
in junction dynamics and integrity. Here, we aimed to find novel
clues as to how caveolin-1 controls cell adhesion and barrier function
in endothelial cells. To this end, we demonstrated a caveolin-1-
controlled mechanism that is directly linked to VE-cadherin-mediated
cell adhesion in response to thrombin stimulation.
The most significant findings of this study are (i) that caveolin-1
associates with and is targeted by the VE-cadherin/catenin complex
to endothelial cell junctions and (ii) that phosphocaveolin-1 is critical
for the opening of endothelial cell junctions in response to thrombin
stimulation. Association of catenins with caveolin-1 was demonstrated
by IPs, GST-pull-down assays (Figure 1), and expression studies using
CHO cells (Figure 2) and a b-catenin-knockout cell line (Figure 3). The
data are in line with other reports showing that VE-cadherin and E-
cadherin are associated with caveolin-113,15 as well as the identifi-
cation in zebrafish of a binding motif that mediates the interaction
of caveolin-1 with b-catenin.16 Thus, a direct interaction of mamma-
lian caveolin-1 with mammalian b-catenin might occur, but this has
to be tested in the future.
The functional relevance of our findings was further demonstrated
in primary cultures of HUVEC and a caveolin-1-knockout endothelial
cell line after stimulation with thrombin. Certain signalling pathways
become activated by thrombin through G-protein-coupled PAR-1.
This includes activation of Rho-GTPases, non-receptor tyrosine
kinases such as Pyk2 and src-kinase, myosin light chain kinases and
phosphatases,33,34 and actin/myosin filament sliding mechanisms.35,36
Furthermore, caveolin-1 becomes tyrosine phosphorylated by
src-kinases,7 a process that has also been described to be critical in
barrier function regulation.34 Indeed, thrombin induces tyrosine phos-
phorylation of caveolin-1 by hitherto unknown non-receptor tyrosine
kinases, which in turn increases complex formation with both
b-catenin and g-catenin and weakens binding to VE-cadherin. This is
reflected in the decreased amounts of both b-catenin and caveolin-1
that were precipitated from soluble Triton X-100 cell extracts with
VE-cadherin and the increased amounts of caveolin-1 that were
Figure 5 Thrombin-induced reorganization of junction molecules. Immunolabelling of HUVEC after treatment with either 1 U/mL thrombin or
buffer as indicated. (A–D) Thrombin stimulation induced a transient redistribution of VE-cadherin, b-catenin, and caveolin-1 into a rope ladder-like
pattern within 15 min that recovered after 120 min. Boxes indicate areas of higher magnification. Arrows point to cell junctions. Under control con-
ditions (B) a fraction of caveolin-1 co-localized at cell junctions and with a fraction of b-catenin (yellow staining, arrowheads). Thrombin administration
dissociated caveolin-1 from cell junctions and (C) colocalized with rope ladder-like b-catenin staining (arrows). (D) Within 120 min both caveolin-1
and b-catenin reappeared at junctions as under control conditions. Panels on the right-hand side show magnification of the respective boxes. Nuclei
are stained with DAPI. Scale bars ¼ 20 mm.
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Figure 6 Phosphocaveolin-1 is required to open cell junctions in response to thrombin. (A) Quantitative western blot of phosphocaveolin-1 using a
Y-14 phosphocaveolin-1-specific antibody after IP of adherens junction molecules from HUVEC treated with thrombin as indicated.
Phosphocaveolin-1 was transiently increased in the b-catenin IP, whereas the amount of phosphocaveolin-1 that associated with VE-cadherin
remained unchanged. Pervanadate (PV) served as a positive control. *P, 0.05; **P, 0.005; ***P, 0.0005. (B) Expression of caveolin-1 and the
14 Y/F-caveolin-1-mutant in cav-12/2 endothelial cells by lentiviral gene transfer. Alpha-tubulin served as internal protein loading control. (C)
TER of endothelioma cells as indicated in response to thrombin. Only caveolin-1-expressing cells showed the characteristic decrease in TER. (D)
Quantitative western blotting of b-catenin IP from endothelioma cells as indicated. (E) Immunoprecipitates of b-catenin from indicated cell lines
were probed for caveolin-1 after thrombin stimulation. (E1) Western blot of caveolin-1 from total Triton X-100 cell extracts as indicated. a-
tubulin served as a further loading control. (F ) IP of VE-cadherin from indicated cell lines was probed for b-catenin after thrombin stimulation.
One representative blot from three independent experiments is shown. Quantitative analysis of three independent experiments is shown.
*P, 0.05; **P, 0.005.
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precipitated with b- and g-catenin. The non-ionic detergent Triton
X-100 dissociates protein complexes only when the association is
weak,37 and it is reasonable to assume that the b-catenin/-
phosphocaveolin-1 complex is dissociated from VE-cadherin after
Triton X-100 extraction. These results are also consistent with the
localization of caveolin-1 and b-catenin in a rope ladder-like pattern
after thrombin stimulation (Figure 5C). While histamine stimulation
has been shown to increase the association of b-catenin with
PECAM-1,38 a mechanism that might also reduce the association of
b-catenin with VE-cadherin, the interaction of PECAM-1 with
caveolin-1 seems to be of less importance after thrombin stimulation
(Figure 4B and I ). Another possible role of caveolin-1 in the regulation
of endothelial barrier function was recently reported in the form of
hydrogen peroxide-induced dissociation of b-catenin and caveolin-1
in rat lung microvascular endothelial cells.13 Hydrogen peroxide is
an important but also an unspecific stimulus that leads to increased
endothelial permeability, and a different mechanism utilizing
caveolin-1- seems to be involved. This shows the existence of differ-
ent mechanisms that seem to depend on the respective stimuli but
might also depend on extraction buffers and cell type. However,
both studies13 (and the present study) point to the critical importance
of caveolin-1 in barrier function regulation.
Catenins occupy a strategically important position at the adherens
junctions since they link VE-cadherin to the cytoskeleton. Weakening
of this interaction by phosphocaveolin-1, together with Rho activation
in response to thrombin stimulation, might facilitate uncoupling of the
VE-cadherin/catenin complex from the junction-associated actin
cytoskeleton, leading to the formation of stress fibres and the devel-
opment of contractile forces.35 In addition, caveolin-1 interacts with
the actin filament cross-linking protein filamin,39 and this interaction
might be important in uncoupling the VE-cadherin/catenin complex
from the actin cytoskeleton. Previous work showed lateral clustering
of the VE-cadherin/catenin complex and a rac-1-dependent recruit-
ment of actin filaments to adherens junctions in response to physio-
logical shear stress, a stimulus that tightens endothelial cell
junctions.5 Thus, thrombin-induced weakening of b- and g-catenin
binding to VE-cadherin might also lead to reduced lateral clustering
of the VE-cadherin/catenin complex. However, whether and to
what extent lateral clustering contributes to the regulation of the
VE-cadherin/catenin complex and its connection to the actin cytoske-
leton during inflammation has yet to be determined.
Here, we show that PAR-1 activation leads to phosphorylation of
caveolin-1, which in turn is essential to open endothelial cell junctions
but is independent of the signalling that leads to ERK1/2 phosphoryl-
ation.40 Thus, PAR-1-mediated activation of caveolin-1 turns on mul-
tiple pathways that appear to be independent of each other. The data
are in line with b-catenin-mediated, thrombin-induced long-term
stimulation of gene expression,41 and support the concept that
b- and g-catenin are targets in the opening of cell junctions. Other
stimuli such as histamine also target b-catenin,42 and g-catenin was
shown to be targeted by VE phosphotyrosine phosphatase during leu-
cocyte diapedesis.43 We assume that caveolin-1 plays a role in these
processes as well, but this has to be investigated in a separate study.
The role of caveolin-1 in the regulation of endothelial barrier func-
tion has also been studied using a siRNA approach. Depletion of
caveolin-1 increases constitutive endothelial permeability and
reduces VE-cadherin and b-catenin levels12 (Supplementary material
online, SI-5). However, the caveolin-1-knockout cells still formed a
barrier (Supplementary material online, SI-5) and responded to
thrombin with a slight increase in barrier function, as seen by an
increase in TER. This phenomenon demonstrated a counter-
regulatory mechanism that is activated in parallel by thrombin but is
independent of caveolin-1. In contrast, caveolin-1 is essential in the
opening of cell junctions in response to thrombin. Thrombin increases
paracellular permeability in a process requiring the phosphorylation of
caveolin-1 at tyrosine 14.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
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